Patent · US Active

JAK inhibitor

US10617690B2 · kind B2 · utility

0Cited by
2References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 19, 2016
Grant dateApr 14, 2020
Priority date
Expiry dateJun 16, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention discloses a series of JAK inhibitors, and particularly discloses a compound of formula (I) or a pharmaceutically acceptable salt thereof and the use thereof in preparation of drugs for treating diseases related to JAK.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.